TY - JOUR
T1 - Deletion mapping of 14q32 in human neuroblastoma defines an 1,100-kb region of common allelic loss
AU - Hoshi, Masato
AU - Shiwaku, Hiromi O.
AU - Hayashi, Yutaka
AU - Kaneko, Yasuhiko
AU - Horii, Akira
PY - 2000
Y1 - 2000
N2 - Background. We analyzed loss of heterozygosity (LOH) in 54 primary neuroblastomas (NBs) using 12 microsatellite markers on 14q32, and found that 31% (17/54) NBs showed LOH. Procedure. The smallest region of overlap (SRO) was identified between D14S62 and D14S987. Results. There was no statistical correlation between LOH and any clinicopathologic features, including age, stage, amplification of MYCN, and ploidy. A sequence-ready bacterial artificial chromosome (BAC) contig was constructed, and the minimum tiling path of six BACs covered the SRO; the physical length of this region was no larger than 1,000 kb. Conclusions. Our findings support the existence of a putative tumor-related gene on 14q32 for the tumorigenesis of NB. (C) 2000 Wiley-Liss, Inc.
AB - Background. We analyzed loss of heterozygosity (LOH) in 54 primary neuroblastomas (NBs) using 12 microsatellite markers on 14q32, and found that 31% (17/54) NBs showed LOH. Procedure. The smallest region of overlap (SRO) was identified between D14S62 and D14S987. Results. There was no statistical correlation between LOH and any clinicopathologic features, including age, stage, amplification of MYCN, and ploidy. A sequence-ready bacterial artificial chromosome (BAC) contig was constructed, and the minimum tiling path of six BACs covered the SRO; the physical length of this region was no larger than 1,000 kb. Conclusions. Our findings support the existence of a putative tumor-related gene on 14q32 for the tumorigenesis of NB. (C) 2000 Wiley-Liss, Inc.
KW - BAC
KW - Chromosome arm 14q
KW - LOH
KW - Neuroblastoma
KW - Tumor suppressor gene
UR - http://www.scopus.com/inward/record.url?scp=0033653344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033653344&partnerID=8YFLogxK
U2 - 10.1002/1096-911X(20001201)35:6<522::AID-MPO4>3.0.CO;2-6
DO - 10.1002/1096-911X(20001201)35:6<522::AID-MPO4>3.0.CO;2-6
M3 - Article
C2 - 11107107
AN - SCOPUS:0033653344
SN - 1545-5009
VL - 35
SP - 522
EP - 525
JO - Medical and Pediatric Oncology
JF - Medical and Pediatric Oncology
IS - 6
ER -